Balyasny Asset Management L.P.
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 1218710
Chicago, IL
Position in ACAD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,817,007
+$2,850,028 QoQ
Shares Held
388,024
+24.0% QoQ
Ownership
0.225%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#53
of 354 holders
Holding Since
Jun 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Derivatives in ACAD
reported options exposure · as of Mar 31, 2025CallValue
$1,661,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $2,351,657,469 across 178 Biotechnology names. ACAD ranks #68 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | 1,665,102 | $221,008,988 | |||
| 2 | INSM |
INSMED Inc
|
1,326,430 | $141,423,966 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,230,052 | $91,614,272 | |
| 4 | ABVX |
Abivax S.A.
|
603,840 | $80,467,718 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
145,005 | $72,028,333 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
2,016,379 | $63,032,007 | |
| 7 | CYTK |
Cytokinetics Inc
|
711,676 | $60,627,678 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
1,054,613 | $60,344,955 |
All Filings in ACAD
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,817,007 | 388,024 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,966,979 | 312,982 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $1,661,000 | 100,000 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $7,283,518 | 396,922 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,295,917 | 1,124,572 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,547,372 | 772,146 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $3,250,000 | 200,000 | Call | Sole | 2024-08-14 | |
| 2023-12-31 | $9,420,395 | 300,875 | Shares | Other | 2024-02-14 | |
| 2023-12-31 | $3,131,000 | 100,000 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $340,067 | 16,318 | Shares | Other | 2023-11-14 | |
| 2022-12-31 | $41,041 | 2,578 | Shares | Other | 2023-02-14 | |
| 2022-06-30 | $146,395 | 10,390 | Shares | Other | 2022-08-15 | |
| 2021-12-31 | $1,999,934 | 85,687 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,142,324 | 128,978 | Shares | Sole | 2021-12-01 | |
| 2020-09-30 | $6,187,500 | 150,000 | Call | Sole | 2020-11-16 | |
| 2020-09-30 | $2,799,390 | 67,864 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $377,678 | 7,792 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||